| |
 |
|
Class Information
Number: 514/167
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin d, etc.) doai
Description:
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6858595 |
Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
Feb. 22, 2005 |
| 6849613 |
Multiple antioxidant micronutrients |
Feb. 1, 2005 |
| 6846811 |
(20S) 1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D3 and their uses |
Jan. 25, 2005 |
| 6844331 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D3 and their uses |
Jan. 18, 2005 |
| 6844330 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-NOR-vitamin D3 and their uses |
Jan. 18, 2005 |
| 6844332 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D3 and their uses |
Jan. 18, 2005 |
| 6835722 |
Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
Dec. 28, 2004 |
| 6835723 |
2-methylene-19-nor-20(S)-1.alpha.-hydroxy-bis-homo-pregnacalciferol in crystalline form |
Dec. 28, 2004 |
| 6815415 |
Diagnosis and treatment of malignant neoplasms |
Nov. 9, 2004 |
| 6814983 |
Compositions and methods for nutrition supplementation |
Nov. 9, 2004 |
| 6806262 |
2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
Oct. 19, 2004 |
| 6790462 |
Calcium dietary supplement |
Sep. 14, 2004 |
| 6787529 |
Topical composition |
Sep. 7, 2004 |
| 6780508 |
Powder particles with smooth surface for use in inhalation therapy |
Aug. 24, 2004 |
| 6774111 |
Carbohydrate system and a method for providing nutrition to a diabetic |
Aug. 10, 2004 |
| 6761912 |
Composition for increasing bone density |
Jul. 13, 2004 |
| 6759396 |
Compositions based on a synergistic mixture of at least one VDR ligand and a retinoid |
Jul. 6, 2004 |
| 6753325 |
Composition and method for prevention, reduction and treatment of radiation dermatitis |
Jun. 22, 2004 |
| 6753013 |
Pharmaceutical composition |
Jun. 22, 2004 |
| 6716454 |
Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof |
Apr. 6, 2004 |
| 6703380 |
Prevention of cancer |
Mar. 9, 2004 |
| 6696431 |
26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds |
Feb. 24, 2004 |
| 6689766 |
Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same |
Feb. 10, 2004 |
| 6683069 |
Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin |
Jan. 27, 2004 |
| 6680309 |
Method of treating hyperproliferative diseases using active vitamin D analogues |
Jan. 20, 2004 |
| 6673782 |
Treatment of systemic lupus erythematosis |
Jan. 6, 2004 |
| 6667298 |
26,27-Homologated-20-EPI-2-alkyl-19-NOR-vitamin D compounds |
Dec. 23, 2003 |
| 6664246 |
Pharmaceutical composition |
Dec. 16, 2003 |
| 6656928 |
Composition for the topical treatment of rashes, dermatoses and lesions |
Dec. 2, 2003 |
| 6642218 |
Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
Nov. 4, 2003 |
| 6630516 |
Methods and compositions for preventing and treating chronological aging in human skin |
Oct. 7, 2003 |
| 6627622 |
(20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
Sep. 30, 2003 |
| 6610670 |
Cyclodextrin-drospirenone inclusion complexes |
Aug. 26, 2003 |
| 6599513 |
Products for topical applications comprising oil bodies |
Jul. 29, 2003 |
| 6596306 |
Drug delivery system:formulation for fat-soluble drugs |
Jul. 22, 2003 |
| 6585991 |
Termite bait matrix |
Jul. 1, 2003 |
| 6583129 |
Administration of non-oral androgenic steroids to women |
Jun. 24, 2003 |
| 6582710 |
Products for topical applications comprising oil bodies |
Jun. 24, 2003 |
| 6579861 |
1.alpha.-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses |
Jun. 17, 2003 |
| 6573242 |
Dihydroxypropyl cysteine peptide and agent containing this peptide |
Jun. 3, 2003 |
| 6573255 |
Vitamin D analogues |
Jun. 3, 2003 |
| 6573256 |
Method of inhibiting angiogenesis using active vitamin D analogues |
Jun. 3, 2003 |
| 6565891 |
Nutritional supplement for children |
May. 20, 2003 |
| 6566351 |
Malignant tumor metastasis inhibitors |
May. 20, 2003 |
| 6566352 |
1 .alpha.-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
May. 20, 2003 |
| 6562378 |
Nutritional supplement for adolescents |
May. 13, 2003 |
| 6559139 |
Combination chemotherapy |
May. 6, 2003 |
| 6559138 |
3-Desoxy-vitamin D3 analog esters |
May. 6, 2003 |
| 6548489 |
Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same |
Apr. 15, 2003 |
| 6544969 |
26,27-homologated-20-epi-2-alkyl-19-nor-vitamin D compounds |
Apr. 8, 2003 |
|
|
|
